Summary: Quantification of human brain muscarinic cholin ergic receptors was investigated with the use of e 'ClN-methyl-4-piperidyl benzylate (NMPB) and positron emission tomog raphy (PET). Whole-brain uptake of NMPB at 90 to 110 min utes after intravenous injection was approximately 10% of the administered dose. The initial cerebral distribution of NMPB corresponded to the pattern of cerebral perfusion; however, at progressively longer postinjection intervals, regional distinc tions consistent with muscarinic receptor binding were evident: activity at 90 to 110 minutes postinjection was highest in the striatum and cerebral cortex, intermediate in the thalamus and pons, and lowest in the cerebellum. After the development of a chromatographic system for isolation of authentic e 'ClNMPB in plasma, tracer kinetic modeling was used to estimate recep tor binding from the cerebral and arterial plasma tracer time courses. Ligand transport rate and receptor-binding estimates were obtained with the use of compartmental models and ana lytical methods of varying complexity, including a two parameter pixel-by-pixel-weighted integral approach and re gional least-squares curve-fitting analyses employing both two and three-compartment model configurations. In test-retest ex periments, precision of the methods and their abilities to dis tinguish altered ligand delivery from binding in occipital cortex during an audiovisual presentation were evaluated. Visual Changes in the number or function of muscarinic cho linergic receptors (mAChRs) and cholinergic synapses have been proposed in a number of neurologic and psyReceived September II, 1997; final revision received November 7, 1997; accepted November 10, 1997.
chromatographic system for isolation of authentic e 'ClNMPB in plasma, tracer kinetic modeling was used to estimate recep tor binding from the cerebral and arterial plasma tracer time courses. Ligand transport rate and receptor-binding estimates were obtained with the use of compartmental models and ana lytical methods of varying complexity, including a two parameter pixel-by-pixel-weighted integral approach and re gional least-squares curve-fitting analyses employing both two and three-compartment model configurations. In test-retest ex periments, precision of the methods and their abilities to dis tinguish altered ligand delivery from binding in occipital cortex during an audiovisual presentation were evaluated. Visual Changes in the number or function of muscarinic cho linergic receptors (mAChRs) and cholinergic synapses have been proposed in a number of neurologic and psy-stimulation increased the occipital blood-to-brain NMPB trans port rate by 25% to 46% in estimates arising from the various approaches. Weighted integral analyses resulted in lowest ap parent transport changes and in a concomitant trend toward apparent binding increases during visual activation. The re gional least-squares procedures were superior to the pixel-by pixel method in isolating the effects of altered tracer delivery from receptor-binding estimates, indicating larger transport ef fects and unaltered binding. Precision was best (less than 10% test-retest differences) for the weighted integral analyses and was somewhat lower in the least-squares analyses (10-)5% differences). The authors conclude that pixel-by-pixel weighted integral analyses of NMPB distribution introduce transport biases into receptor-binding estimates. Similar con founding effects also are predicted in noncompartmental analy ses of delayed radiotracer distribution. The use of regional nonlinear least-squares fitting to two-and three-compartment models, although more labor intensive, provides accurate dis tinction of receptor-binding estimates from tracer delivery with acceptable precision in both intra-and intersubject compari sons. Key Words: Human brain-Kinetic modeling Muscarinic receptor-N-methylpiperidyl benzilate-Positron emission tomography. chiatric illnesses. For example, losses of markers for cholinergic neurons and presynaptic terminals, as well as more controversial mAChR changes, have been sug gested in postmortem and biopsy studies of patients with Alzheimer's disease (Davies and Maloney, 1976; Sims et aI. , 1983; Mash et aI. , 1985; DeKosky et aI. , 1992) . Dur ing the course of Huntington's disease, there is a loss of striatal mAChRs, reflecting reduction in intrinsic striatal neurons (Enna et aI. , 1976; Wastek and Yamamura, 1978) . Functional alterations of the mAChR also have been hypothesized on the basis of clinical observations in idiopathic dystonia (Fahn, 1983 ), Parkinson's disease 1.-K. ZUBIETA ET AL. (Ruberg et aI. , 1982) , and schizophrenia (Tandon and Greden, 1989) , and in the affective disorders (Janowski et aI. , 1972) .
Previous studies have sought in vivo muscarinic recep tor quantification using either single-photon emission computed tomography (SPECT) or positron emission tomography (PET) to image the human brain distribu tions of muscarinic antagonist radioligands. Precise quantification of mAChRs has, however, been hampered by the in vivo kinetic behaviors of the radiotracers em ployed, including [ II C]scopolamine (Frey et aI. , 1992) , [ II C] tropanyl benzilate (Koeppe et aI. , 1994) , [ 11 C]benz tropine (Dewey et aI. , 1990) , [ 123 I]3 -quinuclidinyl-4-iodobenzilate (Eckel man et aI. , 1984; Sawada et aI. , 1990) , and e
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I]iododexetimide (Mueller-Gartner et aI. , 1992) . These agents share relatively slow dissociation rates from the mAChRs, which may limit the precision of their uses for in vivo binding site density estimates. Slow dissociation from receptors precludes the use of equilib rium binding or of single scan analyses because true equilibrium is not achievable during the imaging times permitted by the isotopic half-lives of the tracers. Thus, compartmental kinetic analyses must be employed to es timate binding with these agents. However, when the rate of ligand binding is rapid relative to the rate of its trans port from blood to tissue, tissue activity levels are deliv ery limited and receptor estimates become imprecise and prone to bias from effects of altered blood flow.
We have developed the novel, radiolabeled nonsub type-selective muscarinic receptor antagonist [ II C]N methyl-4-piperidyl benzylate (NMPB; Mulholland et aI. , 1988) which possesses more favorable kinetic properties in preliminary animal (Buck et aI. , 1996) and human studies than prior ligands (Frey et aI. , 1992; Koeppe et aI. , 1994) . In the present study, we implement and char acterize alternatives for the analysis of [ II C]NMPB dis tribution and evaluate the specificity of binding estimates derived from several kinetic modeling alternatives in healthy human volunteers. Two-and three-compartment model configurations and pixel-by-pixel-weighted inte gral versus regional nonlinear least-squares fitting pro cedures are compared for their abilities to describe the in vivo kinetics of NMPB and to differentiate the radio tracer delivery and binding processes. In a test-retest paradigm, we assess the degree of independence of re ceptor estimates from altered tracer delivery, as well as the intrasubject variability of the measurements.
METHODS

Subjects
Nineteen young healthy volunteers (24 ± 4 years of age; 11 men, 8 women) were recruited via local advertisement and enrolled after normal physical and neurologic examination re sults. Participants had no current or prior significant medical, neurologic, or psychiatric illness and reported no family history J Cereb Blood Flow Metah, Vol. 18, No.6, 1998 of neurologic or psychiatric illness in first-degree relatives. Subjects with history of drug or alcohol abuse, cigarette smok ing, or excessive consumption of caffeine (>300 mg/day) were excluded. The studies were approved by The University of Michigan Institutional Review Boards governing the use of human subjects and the use of radionuclides in human research, and written informed consent was obtained before all experi mental procedures.
Positron emission tomography data acquisition and experimental designs
In initial studies of NMPB distribution kinetics, seven sub jects underwent a single dynamic sequence of scans with eyes and ears unoccluded in a room with dimmed lighting. In sub sequent model validation experiments, one group of six sub jects completed two identical baseline studies. A second group of six subjects were studied once with eyes patched and once while watching a videotape during the entire imaging period, in a balanced design (baseline-stimulation or stimulation baseline, 3 subjects each). Audiovisual stimulation was initi ated 5 minutes before the injection of the radioisotope and consisted of a popular adventure screenplay selected by the subject to ensure continuous attention during the study.
At the beginning of imaging sessions, radial artery and an tecubital vein catheters were placed for collection of arterial blood samples and for radiotracer administration, respectively. Subjects then were positioned supine in the gantry of a CTI/ Siemens 931/08-12 tomograph (Knoxville, TN, U.S.A.), which acquires 15 contiguous slices from a 10-cm axial field of view with reconstructed in-plane resolution of 8 to 9 mm full width at half-maximum for the current studies.
Each scan was initiated after the intravenous bolus adminis tration of no-carrier-added, high-specific activity (> 1000 Ci/ mmol) C lC]NMPB (Mulholland et aI., 1988) , at a dose of 20 ± 2 mCi. A sequence of 18 PET scans was acquired, covering 110 minutes (2 x 30 seconds, 4 x 1 minute, 2 x 2.5 minutes, 2 x 5 minutes, 7 x 10 minutes, I x 20 minutes). Blood samples were withdrawn from the radial artery every 10 to IS seconds for the first 2 minutes of the scanning period, and then at 2.5, 3, 4, 5, 7.5, 10, 15, 20, 30, 45, 60, 85 , and 110 minutes postinjection. In subjects undergoing two consecutive studies, lllC]NMPB administrations were separated by at least 130 minutes to allow isotopic decay and biologic clearance of the previously admin istered tracer before initiating the second scan.
In visual stimulation experiments, both NMPB studies were preceded by the measurement of cerebral blood flow (CBF) after the intravenous injection of 80 ± 6 mCi C50]H20, to assess the effect of visual stimulation in each subject. A dy namic sequence of nine scans was acquired over 6 minutes. The arterial blood concentration of C50]H20 was obtained by con tinuous counting from the radial artery catheter using a flow through plastic scintillation detector (Hutchins et aI., 1986) . Cerebral blood flow was calculated by a weighted integral method (Alpert et aI., 1984) , omitting the first 30 seconds of data, as described previously (Koeppe et aI., 1987) .
Compartmental modeling of [ ll C]NMPB transport and binding
The tracer kinetic analyses applied to [11C]NMPB have been described in detail in prior studies with other radiotracers (Ko eppe et aI., 1992; . A general model depicting the distri bution of binding site radioligands in brain, which includes a plasma compartment and three tissue compartments, was em ployed (Fig. 1) . The tissue compartments represent free, non specifically bound, and specifically bound radiotracer pools, and 10) and is designated k2"· with intercompartmental exchange described by six first-order kinetic rate constants (K I through k6) when the administered radioligand occupies only a negligible fraction of the available receptors. The kinetic parameters are defined in the four compartment model as follows: KI = jEo = fil -e-p s ,, ) (mL plasmalmL brain per min) (1)
where f is cerebral blood flow (mL plasma/mL brain/minute), Eo is the single-pass extraction fraction of the ligand across the blood-brain barrier, PS is the capillary permeability surface area product (mL plasma/mL brain/minute), k o n is the bimo lecular association rate between ligand and receptor (mL brain/ mol/minute), B m ax' is the density of available receptors (moU mL brain), and k off is the dissociation rate of ligand from the receptor (min-I ). The model parameters are related to the equi librium ligand-binding constant for NMPB at the receptor site, kd ' as follows:
and thus:
The ratio of receptor-related parameters B m ax' Ikd is propor tional to receptor binding, provided that kd is similar for all receptors, and has been introduced previously as the "binding potential" by Mintun et al. (1984) . The aforementioned general model is described by more in dependent variables than may typically be estimated from a single tracer injection study, thus, simplifications were ex plored. A three-compartment, four-parameter model was con figured, which includes blood-to-brain ligand transport (K I ), the free plus nonspecific tissue ligand distribution volume (DV'), and the receptor-binding and dissociation rate constants (k 3 ' and k4). This configuration combines the free and nonspe cific pools into a single compartment, assuming that the rates of exchange between the free tissue and the nonspecific binding pools (k, and k6) are rapid compared with the other model parameters (K I through k4). In the simplified three compartment model (Fig. I) , the rate constants are:
wherc DV' is the summed distribution volumes of the com bined free and nonspecifically bound compartments (mL plasma/mL brain). Assuming the free distribution volume to be I (K I = k2), DV' is equivalent to the quantity (I + ks/k6) in the four-compartment model configuration and reflects the appar ent increase in size of the receptor-binding precursor compart ment because of the presence of nonspecific binding. A further simplified two-compartment, two-parameter model also was evaluated. If, in addition to rapid equilibration of free and nonspecific tracer compartments, the specific binding and dissociation rates (k3' and k4) are rapid compared with the blood-brain transport parameters (K I and k2')' the model can be reduced to two compartments and two kinetic parameters (Fig. I) . In this simplified construct, a single tissue com partment incorporates free, nonspecifically bound, and specifically bound tracer with a new derived rate constant (k2"), reflecting the loss of tracer from the combined tissue compartment to plasma as follows:
= DVF+NS + DV F (B max'/ K ,, ) where DV" is the apparent distribution volume of the summed free, nonspecific binding, and specific binding tissue compart ments (K/k2"). In this model, receptor information is repre sented in the DV" parameter (Frey et aI., 1991) . As the ratio of association to dissociation rates (k 3 /k4) becomes progressively higher, the specific distribution volume term increases, leading to linear, positive correlation between DV" and local receptor density (Koeppe et aI., 1991) .
Development of rapid plasma NMPB chromatography
Methodology for the separation of NMPB from its labeled metabolites in blood was developed in a manner similar to that used for other tracers in our laboratory (Frey et aI., 1991; . Rapid column chromatographic separation with stringent sol vent elution conditions and correction for recovery of the un metabolized tracer using a tritiated internal standard was em ployed. This procedure allows metabolite correction of a larger number of samples containing short-lived radiotracers than is feasible by high pressure liquid chromatography.
The chromatographic behaviors of NMPB and its radio la beled metabolites were studied after their isolation from a 200-g male Sprague-Dawley rat. Fifteen minutes after intrave nous administration of I mCi of l 3 H]NMPB (custom synthesis, New England Nuclear, Boston, MA, U.S.A.), samples of liver, brain, and arterial plasma were obtained. Solid tissues were homogenized in 4 vol of 95% ethyl alcohol (EtOH). Plasma underwent deproteinization by the addition of 1 vol of 95% EtOH. The ethanolic suspensions were then centrifuged for 1 minute at 15,000 x g. Aliquots of the supernatants and of the original homogenates were assayed by liquid scintillation spec troscopy both before and after drying at 60°C to 70°C to detect the possible presence of volatile radioactive species. Additional aliquots of the ethanolic supernatants were concentrated under vacuum and then underwent chromatography on silica thin layer chromatographic plates (No. 5721, E. Merck, Darmstadt, Germany) with a triethylamine:diethyl ether:dichlorometha ne:ethanol (I: 1 0: 15: I) mobile phase. After development and drying, plates were sprayed with a f1uorographic enhancer (En 3 hance, New England Nuclear, Boston, MA, U.S.A.) and apposed to x-ray film (Type SB, Eastman Kodak, Rochester, NY, U.S.A.) for 7 days at -70°C. The autoradiograms were used to locate and recover major radiolabeled species from the plates.
The rapid separation of [ 3 HjNMPB from its major radiola beled metabolites was investigated with the use of Sep-Pak C I X cartridges (Waters, Milford, MA, U.S.A.). Columns were pre pared by prewashing with 0.1 mL triethylamine, followed by J 0 mL of EtOH, and finally by 10 mL of borate-buffered saline eBBS: sodium chloride 137 mmol, sodium borate 10 mmol; pH 10). Samples of authentic eHjNMPB or labeled metabolites obtained from rat liver chromatography were added in J-mL volumes of BBS to the Sep-Pak columns. Columns then were washed with mobile phases of various EtOH-BBS content (10-50% EtOH). The eluted fractions were collected and assayed by liquid scintillation spectroscopy to optimize distinct elution patterns of NMPB versus its polar metabolites.
Routine metabolite correction of arterial plasma [ l1 C]NMPB input functions
A total of 14 plasma samples were analyzed and corrected for the presence of metabolites during each dynamic NMPB
PET scan. Arterial blood samples were centrifuged, and 0.4 mL aliquots of plasma were mixed with 0,6 mL of BBS containing 0.01 f,LCi of eH]NMPB and then applied to Sep-Pak C I 8 col umns. A metabolite fraction was obtained by washing the col umn with 9 mL of 36% EtOH:BBS. An authentic NMPB frac tion then was eluted with 5 mL of absolute EtOH. The r"ClNMPB and r"Clmetabolite fractions were assayed in a sodium iodide well counter followed by liquid scintillation spectroscopy of aliquots determined after decay of the carbon II. The NMPB fraction was corrected for recovery on the basis of the distribution of the [ 3 H]NMPB, and the fraction of total activity in the original plasma sample corresponding to un changed NMPB was calculated as described previously (Frey et aI., 1992) .
Parametric image generation
Individual frames from each dynamic NMPB emission im age sequence were reconstructed with calculated attenuation correction using an ellipse-fitting routine. Reconstructed im ages then were realigned to correct for patient motion that may have occurred during the sequence on the basis of labeled beads (1-2 mm in diameter), which were placed at various points on the subject ' s scalp before scanning. Six to 8 f,LCi of r I I ClNMPB were used to label each of the beads. The approxi mate locations of each of three beads were identified manually in the 17th frame of the study and used as base orientation. The precise (x, y, z) coordinates of the centers of activity were then automatically determined based on the activity distribution in the vicinity of the beads and the measured point spread function of the tomograph. An automated routine subsequently located and calculated the coordinates for each bead in the remaining 17 frames, which then were realigned to the orientation of the base frame, correcting for three translational and three rota tional degrees of freedom to within 0.5 mm and 10, respec tively.
After realignment, the dynamic sequence of emission images and the corresponding metabolite-corrected arterial plasma tracer input function were used to create pixel-by-pixel images of ligand transport (K,) and total tissue distribution volume (DV", see equation 9) on the basis of the simplified, two compartment, two-parameter model. The parametric images were calculated using a weighted integral look-up table analy sis (Alpert et ai., 1984) , as previously applied to estimation of CBF and receptor ligand-binding estimates in our laboratories (Frey et ai., 1991 , Koeppe et ai., 1994 . The first 30 seconds of scan data were omitted from these calculations to reduce cen tral blood volume effects on the estimated parameters (Koeppe et ai., 1987) .
Parametric image calculations performed on a pixel-by-pixel basis are more prone to the effects of statistical uncertainty (noise) than are analyses of region-of-interest data; therefore, a modification of the look-up table approach was employed in the present analyses. Because the measured tissue tracer con centration changes very little as DV" increases at high values (>50 mL plasma/mL brain), the noise in pixel-by-pixel analy ses creates highly variable DV" estimates when k/ is small (leading to high DV"). To reduce this effect, the mapping be tween the look-up table and the optimal k2" was modified (rolled-off) so that small changes in tissue concentration cause smaller changes in the estimate of DV" than they would under other circumstances. Although different than simple temporal or spatial parameter smoothing, the modification achieves a similar qualitative effect on calculated parametric images. The positive consequence of this modification is that pixel-by-pixel functional images can be produced with acceptable noise lev els. The negative consequence is that in high-binding regions, such as the basal ganglia and cortex, DV" is consistently biased, yielding progressive underestimates as DV" increases. How ever, even with this bias in high-binding regions leading to some loss of contrast, the procedure results in better overall distinction between regions of high and low receptor density than methods using either graphical analysis or simple region to-cerebellar ratios.
Regional kinetic analyses of [ ll C]NMPB distribution
Anatomically configured regions of interest were drawn on the Kj maps from the weighted integral pixel-by-pixel analy ses. In test-retest experiments, regions of interest were deter mined on the resting image (baseline-stimulation experiments) or the initial scan (baseline-baseline precision experiments). These regions of interest then were applied to the entire dy namic sequence of individual images of the corresponding sub ject, including both NMPB sequences in test-retest studies and the parametric CBF scans obtained in the baseline-stimulation studies. This resulted in regional NMPB tissue time-activity curves and CBF values for regions of interest corresponding to the frontal and occipital cerebral cortices, putamen, thalamus, pons, and cerebellar hemisphere.
The NMPB regional tissue and the corresponding metabo lite-corrected arterial plasma time-activity curves were ana lyzed according to both the three-compartment and the two compartment kinetic models by nonlinear least-squares curve fitting, using the Marquardt algorithm (Bevington, 1969) with constraints restricting parameters to positive values and data weighting in proportion to the number of detected events before decay correction. The effects of a cerebral blood volume com ponent in the measured PET data and the time disparity be tween the arrival of arterial activity in the wrist versus the brain also were accounted for in each of the models. The time offset was estimated first by fitting the initial 20 minutes of the time activity curve for an entire brain slice at the midthalamic level, using the two-compartment, two-parameter model. In this fit, a fixed, whole-slice cerebral blood volume of 0.035 mLlmL brain (3.5%) was assumed. In all subsequent regional curve fitting for that scan, the temporal offset was fixed to this esti mated value. In the individual regional curve fits, either two or four intercompartmental transfer rate coefficients and local ce rebral blood volume were estimated simultaneously. In report ing and statistical analyses of bilateral structures, left and right hemispheric parameters were averaged on an individual scan basis.
Statistics
Statistical evaluations of the test-retest experiments were conducted separately according to both experimental protocol (baseline-baseline or baseline-visual stimulation) and analytic method (2-parameter pixel-by-pixel-weighted integral, 2-parameter regional least squares, or 4 parameter regional least squares). We hypothesized that no changes in the binding should occur between baseline and visual stimulation, although Kj should increase in the occipital cortex during visual stimu lation on the basis of increased synaptic activation. Paired, two-tailed Student ' s t tests were used for comparison of re gional values in the test-retest studies at the P < 0.05 level of significance. Comparisons between fits resulting from the two least-squares fitting procedures for each region were made on the basis of two statistical procedures. Residual error, assessed by X2, was evaluated with F tests with a significance threshold of P < 0.05. In addition, the fits were assessed by calculating the information criterion of Akaike (1974) , followed by Stu dent ' s t-test.
RESULTS
Metabolism and chromatography of labeled NMPB
Analyses of rat tissues revealed presence of volatile, radiolabeled species accounting for approximately 50% of plasma, 20% of liver, and less than 5% of cerebral activities. It is notable that this activity, likely represent ing labeled water after N-demethylation of NMPB, is not expected after metabolism of the carbon-II-labeled tracer (see discussion in . Thin-layer chromatography of the nonvolatile activity from liver revealed the presence of a group of very polar metabo lites remaining at the origin or migrating with rf values of less than 0.1 (group I) , metabolite species of intermediate polarity migrating with rf values between 0. 1 and 0.25 (group II) , and eH]NMPB migrating with rf of 0.5, ac counting for 50%, 20%, and 25% of total nonvolatile activity, respectively. In plasma, the same three groups of species accounted for approximately 45%, 2%, and 45% of the nonvolatile activity. Analysis of brain re vealed more than 90% of activity attributable to authen tic eH]NMPB, with an additional band of activity (5% of total) migrating with slightly higher rr than the au thentic tracer. This latter material was evident in both plasma and liver, accounting for 1 % to 2% of total ac tivities, and was identified as a minor contaminant in the starting material, accounting for 1 % of nonvolatile ac tivity injected. Thus, there are peripheral radiolabeled metabolites of NMPB present in peripheral tissues, but not in brain. A minor, less polar species is identified in (---36% Ethano1:64% Saline---)(100% Ethanol) (Fig. 2) .
In arterial plasma samples from human subjects, in travenously administered [ II C]NMPB was metabolized rapidly with polar labeled metabolites detected by 15-minute post-tracer administration (Fig. 3) . At the end of a 11O-minute scanning session, authentic [ II C]NMPB accounted for less than 25% of total plasma activity, emphasizing the necessity of chromatographic correction of plasma curves.
Uptake and distribution of [ ll C]NMPB in human brain
Brain uptake of [ II C]NMPB demonstrated peak activ ity levels between 80 and 110 minutes postinjection in all regions (Fig. 4) . Initial levels of activity were higher in gray matter structures than in white matter, consistent with the pattern of CBF. Whole brain uptake of [ lI C]NMPB at 90 to 110 minutes postinjection averaged 10.5% ± 1.4% of the administered dose, corresponding to an average brain concentration of 3 ± 1 nmol ( Table 1) .
The regional concentration of [ II C]NMPB at 90 to 110 minutes postinjection (Table 2 carinic receptor densities in human brain (Lin et ai. , 1986) .
Pixel-by-pixel and regional [ ll C]NMPB-binding estimates
Pixel-by-pixel parametric estimates of NMPB KJ were similar across gray matter brain regions, ranging from 0.36 to 0.47 mL plasma/mL brain/minute, with coeffi cients of variation (COY) between 7% and 17% (Table  2 ; Fig. 5 ). NMPB DY" values corresponded in rank order to the pattern of tracer concentration observed at 90 to 110 minutes postinjection but displayed much broader dynamic range, with COY ranging from 24% (neocorti- * Calculated based on the injected activity and the volume-weighted average of [II C]NMPB activity within brain in all scanned slices be tween 90 to 110 minutes after injection, assuming a whole-brain vol ume of 1,237 mL (Frey et ai., 1992) .
t Calculated from the percent brain uptake between 90 to 110 min utes after injection and the specific activity of the injected tracer, as suming a brain volume of 1,237 mL. cal regions) to 33% (cerebellum) . After normalization of regional to whole brain values, COVs were reduced to between 4% and 11 % for both K, and DV". Regional, nonlinear least-squares analyses of NMPB kinetics revealed adequate descriptions of the experi mental data by both the two-and three-compartment ki netic model configurations. "Goodness-of-fit" estimates were not significantly different for the two model con figurations in regions of highest binding, such as the cerebral cortex and striatum. In regions of lower receptor concentration, including the thalamus, pons, and cerebel lum, both residual X 2 and Akaike information criterion analyses indicated significantly better descriptions of the data by the three-compartment model. With this model configuration, estimates of K, and DV' (tissue distribu tion volume of free and nonspecific binding of NMPB) were similar across regions and revealed between subject COVs in the range of 10% to 15% ( Table 3) . Values of the forward binding rate constant, k3', corre sponded to the distribution of mAChRs in human brain but were associated with COVs between 35% and 72%. Mean values for the ligand-receptor dissociation rate k4 were similar across the regions studied, ranging from 0.07 to 0.09 min-I , but like k3', demonstrated relatively high variances (COVs of 28-67%), especially in the cer ebellum. The ratio of k3' Ik4, an estimate of the specific receptor-binding distribution volume ("binding poten tial" in the nomenclature of Mintun et aI. , 1984) , pro vided a broad dynamic range of binding estimates, with COVs ranging from 19% in the putamen to 35% in the cerebellum. This parameter better reflects the known in vitro muscarinic receptor distribution than does untrans formed [ ll C]NMPB activity (see Tables 2 and 3 ).
Precision of NMPB-binding estimates
Estimates of the blood-to-brain NMPB transport rate (K,) were relatively similar across the various kinetic estimation schemes. Parametric values tended to be slightly higher with the regional, three-compartment, nonlinear least-squares procedure than with the pixel-by pixel-weighted integral method, with intermediate re sults obtained with the regional two-compartment least squares method (Tables 4 and 5 ). The regional between subject precision of parametric K I estimates with the three methods was similar, ranging between approxi mately 10% and 20% COY. After normalization to the global mean, the pixel-by-pixel K, values demonstrated increased precision, with COVs in the range of 5% to Values represent the mean and percent COY kinetic parameter estimations from regional least-squares analyses of the three-compartment model configuration for II subjects. Units for K I are milliliters of plasma per milliliter of brain per minute, for k 3 ' and k4 are min-I and for DV', k 3 /k4 and DV" are milliliters of plasma per milliliter of brain.
* Calculated on the basis of the other estimated parameters, according to the relationship given in equation [10] (see Methods). t In vitro muscarinic receptor binding estimates are reproduced from the data of Lim et aI., (1986) , expressed relative to the cerebellum, and are provided for comparison with the PET binding estimates provided by k 3 lk4 and DV".
:j: Data are from the caudate nucleus. Values represent mean and percent COy for NMPB transport (K, ) and tissue distribution volume (OV") obtained from weighted integral, pixel-by-pixel analyses of data from five subjects studies under sequential baseline conditions. Values of K , are expressed in units of milliliters of plasma per milliliter of brain per minute (mL plasma/mL brain/min), while those of OV" are expressed in milliliters of plasma per milliliter of brain (mL plasma/mL brain). %a represents the percent within subject change between scans: %a = I OO[Scan 2 -Scan 1 j/Scan I. There are no significant differences in any region as assessed by paired Student's {-tests at the P � 0.05 significance level.
* Absolute parametric values are expressed in mL plasma/mL brain/min and in mL plasma/mL brain for Kj and OV", respectively.
t Regional values expressed as the ratio to whole brain average from the same scan.
10%. The brain regional pattern of Kl appeared highly conserved both between subjects as well as within sub jects, the latter reflected by interscan differences ranging from -2 % to -20% (average -6%). A trend toward re duced transport values in the second of the two sequen tial studies was noted; however, it did not achieve sta tistical significance in any region with any of the esti mation methods. The ranges and precision of mAChR density estimates varied more extensively between the three analytic meth ods than did the estimates of ligand transport. There was progressive increase in the dynamic range of receptor density estimates from the pixel-by-pixel-weighted inte gral (DY') to the two-compartment regional least squares (DY') to the three-compartment regional least squares analyses (k3' 1k4). The greatest distinction, that between the latter two procedures, is attributable to iso lation of specific from the non saturable ligand distribu tion pools in the three-compartment configuration. In general, the between-subject precision of the three meth ods was similar in the forebrain regions, ranging between 20% and 30% COY. Variances in cerebellar binding es timates were greater with all three methods (COVs 30-47%), owing to the low levels of mAChRs present (Lin et aI., 1986) . Within-subject precision of the parametric binding estimates appeared higher with the pixel-by pixel procedure (range, -6-10% interscan average dif ferences) than with the least-squares regional procedures (-22-16% average differences) . Normalization of the pixel-by-pixel DV" estimates provided further reduction in forebrain intrasubject mean differences to between -5% and 1 %. No significant differences were identified ["ClNMPB, ["ClN-methyl-4-piperidyl benzyl ate; COY, coefficients of variation. Values represent the mean and percent COY of kinetic parameter estimates from regional least-squares analyses of two-and three-compartment model configurations from sequential baseline scans studies in five individuals. Values of NMPB transport (K, ) are expressed in units of milliliters of plasma per milliliter of brain per minute, while those of k,/k4 and OV" are expressed in milliliters of plasma per milliliter of brain. %a represents the percent within subject change between Scan 1 and Scan 2: %a = 100[Scan 2 -Scan I]lScan 1. There are no significant transport or binding parameter differences between scans detected with the use of paired Student's I-tests at the P � 0.05 significance level.
.l Cereh Blood Flow Metab. Vol. 18. No. 6. 1998 between the sequential scans within subjects for any brain region with any of the analysis procedures.
Distinction of NMPB transport and binding in occipital cortex
Visual stimulation resulted in increased primary visual cortex CBF of 74% ± 34% and 51 % ± 12%, for absolute and normalized (to global activity) CBF estimates, re spectively.
Analyses of the relative (expressed as a ratio to the cerebellum) NMPB distribution between 90 and 110 minutes postinjection in the primary visual cortex re vealed a 28 % increase during visual stimulation. Relative occipital uptake in the eyes open condition was 7. 2 ± 1.7 (mean ± SD) compared with 5.6 ± 0.6 in the eyes closed state (P < 0.05, paired Student's t test) . In the frontal cortex, visual simulation was without effect on NMPB activity (4. 7 ± 2. 3 versus 5.3 ± 0.6 in the stimulated and eyes closed states, respectively) .
Pixel-by-pixel-weighted integral tracer kinetic analy ses indicated a significant apparent [ I I C]NMPB transport rate (K1) increase of 28 % and 24% in the primary visual cortex for absolute and normalized (to whole brain) es timates, respectively (Table 6, Fig. 6 ). The apparent in creases in K] averaged 39% and 46% in the occipital cortex, as estimated with the regional, two-compartment and three-compartment model, least-squares procedures, respectively (Table 7) .
Binding parameter values obtained from the pixel-by pixel-weighted integral analysis suggested an insignifi cant 7% increase in the absolute DV" in the occipital cortex during visual stimulation. After normalization to whole-brain DV", the relative occipital cortical estimate increased by 16% (P < 0.05) during visual stimulation. No other regional changes in DV" were identified in either absolute or normalized estimates. Both the re gional two-and three-compartment least-squares proce dures suggested lack of change in occipital cortical bind ing during visual activation, with negative (rather than positive) , insignificant mean differences of -1 % and -6% between scans, respectively.
DISCUSSION
The present studies describe methodology for kinetic determinations of muscarinic receptor binding from the time courses of [ I I C]NMPB activities in arterial blood and brain. Of the analytic strategies for estimating recep tor availability tested, we identified the best fidelity and Values represent mean and percent COY for NMPB transport (K,) and tissue distribution volume (DV") obtained from weighted integral, pixel-by-pixel analyses of data from six subjects studied under baseline and visual stimulation conditions. Values of K, are expressed in units of milliliters of plasma per milliliter of brain per minute (mL plasma/mL brain/min) while those of DV" are expressed in milliliters of plasma per milliliter of brain (mL plasma/mL brain). %t. represents the percent within-subject change during visual stimulation: %t. = 100[Stimulation-Baseline]/ Baseline. *,t Significant differences in paired Student's I-tests at the P � O.OS and P � 0.01 significance levels, respectively. * Absolute parametric values are expressed in mL plasma/mL brain/min and in mL plasma/mL brain for K, and DV", respectively.
preCISIOn from the application of regional, nonlinear, least-squares fitting of either two-or three-compartment kinetic models (Table 3) . Our findings indicate that NMPB may be applied successfully to in vivo muscarinic receptor quantification; however, arterial blood sampling to determine the cerebral tracer input function is essential to the extraction of unbiased binding estimates. Nonlin ear, least-squares kinetic analysis of simple compartmen tal models permits distinction of tracer transport from its tissue binding, even in regions of high receptor concen tration, such as the cerebral neocortex. However, math ematically constrained kinetic analyses, methods em ploying reference brain regions for input fu nction esti mation, or simple tracer activity level analyses are insufficient to eliminate transport (blood flow) biases from binding estimates, as demonstrated by the effects of visual stimulation on the occipital distribution of NMPB in our experiments. However, the present studies do not independently verify the saturable nature of the binding parameters. This would require the administration of pharmacologically significant doses of unlabeled block ers, and complete blockade may be expected to produce severe side effects and toxicity (see discussion in Frey et aI ., 1992) .
Results of the most detailed compartmental model analyzed indicate the presence of substantial specific binding of NMPB in essentially all gray matter regions. Even in the cerebellum, where muscarinic receptor con centration is the lowest of the major cerebral structures (Lin et aI., 1986) , there is appreciable apparent binding ( . :;:
. "" 0. Table 3 and a typical arterial input function.
There is a considerable fraction of bound activity, despite the low cerebellar receptor concentration. This renders the total and free tracer activity curves distinct in both shape and in scale, of NPMB. As a consequence, methods of analysis that rely on the use of cerebellar curves to estimate the arte rial tracer time course (Shinotoh et aI., 1994; Suhara et aI., 1993; may be in substantial error and are ad ditionally sensitive to changes in cerebellar receptor con centration or blood flow. This is illustrated by the pre dicted time courses of total versus free [ " C]NMPB aris ing from a typical arterial time-activity input curve and the popUlation-average cerebellar intercompartmental exchange rate constants (Fig. 7) . Within minutes after injection of NMPB, a substantial portion of cerebellar activity is bound, and after 45 minutes postinjection, bound and free tracer levels essentially are equal. Thus, there is a time-dependent and significant distinction be tween the total and the actual free cerebellar NMPB curves. A further problem with strategies employing a tissue "reference" region in lieu of arterial blood sam pling is illustrated by considering tracer pools in recep tor-rich areas such as the striatum (Fig. 8) . In this in stance, it is evident that rapid NMPB binding depletes tracer from the free and nonspecific binding pools throughout the study. Thus, even if a cerebral region entirely devoid of muscarinic receptors could be identi fied, the level and time-course of activity would not pro vide an accurate estimate of the free NMPB levels in tissues with receptors. Arterial blood sampling and com partmental analysis are, therefore, essential in obtaining accurate in vivo receptor-binding estimates with NMPB and similar tracers. In recent compartmental kinetic analyses of the muscarinic receptor antagonist [ ll C]tro panyl benzilate (Lee et aI., 1996) , for example, we failed to verify the age-related receptor declines suggested by the cerebellar reference approach (Suhara et aI., 1993) .
Here, in addition to the aforementioned kinetic issues, an apparent change in the reference region may have ac counted for most of the reported cerebral binding de cline.
In comparison with muscarinic receptor ligands stud ied previously in our laboratory (Frey et aI., 1992; Koeppe et aI., 1993) cation of the tracer kinetic model (Fig. I ) than do the other agents.
Our modeling experiments objectively evaluated the independence of binding estimates from tracer transport effects employing physiologic visual activation. Using the pixel-by-pixel-weighted integral analysis, a small in crease in apparent receptor binding was noted in the primary visual cortex as a result of stimulation. This effect was statistically significant after normalization to whole-brain average binding values because of the re duction in variance achieved with this procedure. Such apparent receptor differences are not anticipated under normal physiologic conditions and were not apparent when the least-squares regional analyses were applied to the same data. Most likely, some tracer transport effects are propagated procedurally into the receptor-binding pa rameter in the pixel-by-pixel procedure. The effect may be most pronounced in regions of high receptor density (i.e., cerebral cortex or striatum), where bound radio tracer dominates the tissue time-activity curves, and mi nor errors in estimation of tracer delivery have limited impact on the overall goodness of fit. Thus, details of the pixel-by-pixel procedure, including absence of tracer ar rival time-shift correction and lack of a blood volume correction, may have resulted in biases not seen in the regional fits, where these additional factors were taken into consideration. As indicated in the Methods section, our modification of the look-up table approach used in the pixel-by-pixel parametric K l and DY" maps causes underestimation of DY" in high receptor density regions. Without the roll-off modification, parameter maps are unacceptably noisy and difficult to visually analyze. Therefore, despite the bias, the ability to view fu nctional parametric images of the entire brain is important for detection of unanticipated changes. If abnormalities are seen in DY" maps, subsequent region-of-interest analy ses can be made to provide more accurate binding esti mates. In addition, as mentioned previously, the degree of bias in our parametric maps is less than that intro duced by graphical or region ratio-to-cerebellum analy ses.
Regional least-squares fitting with either two-or three-compartment models resulted in comparable esti mates of NMPB transport and binding. Distribution vol ume values from two-compartment fits were not affected significantly by visual stimulation. In the occipital cor tex, the observed mean change in DY" (-I %) was well within the average intrasubject variation noted for other, nonstimulated brain regions (4-12%). Similar results were obtained with the three-compartment model con figuration. In this analysis, binding potential (k3' Ik4; Bmax '/Kd) differences did not change significantly during visual stimulation (-6% difference from baseline), again, well within the range of binding variances in remote brain regions or in the test-retest control experiments.
J Cereb Blood Flow Me/ah. Vol. 18, No. 6. 1998 These observations suggest that excellent physiologic fi delity and relative insensitivity to the confounding ef fects of blood flow alterations are obtainable with either two-or three-compartment models and regional least squares fitting analyses.
Our results indicate the potential for accurate and pre cise determinations of muscarinic receptor binding in the living human brain with the use of [ 11 C]NMPB and PET. This promising radioligand yields valid binding esti mates, however, only in experimental designs incorpo rating direct determinations of the arterial tracer input function and employing subsequent compartmental analyses of plasma and cerebral time-activity curves. The best analytic procedure for obtaining unbiased binding estimates is with the use of a three-compartment model to estimate the binding potential parameter. More sim plified analytic schemes include some bias from tracer delivery (pixel-by-pixel-weightcd integral method) or fail to separate specific binding form nonsaturable tissue tracer pools (both two-compartment analyses). However, a potential limitation of the three-compartment model, as implemented here, is its inability to provide images of the binding and ligand transport parameters. Thus, in future applications, it may be of benefit to calculate and survey pixel-by-pixel K l and DY" maps to identify po tential areas of change, fo llowed by regional three compartment fits to objectively distinguish receptor binding changes from alterations in the delivery of ra diotracer.
